Macropa-NH2 TFA
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-111895B-100 mg |
| Pricing | 100 mg, USD $4500.0 |
| Biological Activity | Macropa-NH2 TFA is the precursor of Macropa-NCS. Macropa-NCS is conjugated to trastuzumab as well as to the prostate-specific membrane antigen-targeting compound RPS-070 and is a promising therapeutic radionuclide applied in the treatment of soft-tissue metastases[1]. |
| Purity | 98.14% |
| MWt | 661.62 |
| Formula | C₂₈H₃₈F₃N₅O₁₀ |